Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Erik van der Burg
AddedFeb 15, 2024
UpdatedMay 31, 2026
Erik van der Burg

Erik van der Burg

Board Member, Siesta Medical

CrunchbaseLinkedInThe Org

Erik van der Burg's Career

Siesta Medical
Siesta Medical

Los Gatos, CA, US

Board Member· Board
Venova Medical
Venova Medical

Los Gatos, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Erik van der Burg's Career

Siesta Medical
Siesta Medical
Series B$1.9M82009Los Gatos, CA, US
Board Member· Board

Leadership at Siesta Medical

John KimJohn KimBoard Member

Similar to Siesta Medical

XII MedicalXII MedicalUnion City, CA, USMedical Devicesest. 2017XII MedicalUnion City, CA, US · est. 2017

XII Medical: Innovating minimally invasive solutions for obstructive sleep apnea treatment.

Series A · $30M29
SomneraSomneraSan Clemente, CA, USMedical Devicesest. 2011SomneraSan Clemente, CA, US · est. 2011

Somnera, a medical device company, enhances lives by tackling Obstructive Sleep Apnea.

Series C · $7.5M30
LinguaflexLinguaflexPittsburgh, PA, USMedical Devicesest. 2007LinguaflexPittsburgh, PA, US · est. 2007

LinguaFlex, Inc: A medical device company revolutionizing sleep apnea treatment with patented technology.

Series A · $11.7M30
Invicta MedicalInvicta MedicalSanta Clara, CA, USMedical Devicesest. 2013Invicta MedicalSanta Clara, CA, US · est. 2013

Invicta Medical: Innovating sleep apnea therapies with cost-effective, patient-friendly neurostimulation wearables.

Series B · $53.6M25
Venova Medical
Venova Medical
Series A$8M72018Los Gatos, CA, US
Co-Founder

Leadership at Venova Medical

Shant VartanianShant VartanianCo-Founder

Similar to Venova Medical

Hemova MedicalHemova MedicalBoston, MA, USMedical Devicesest. 2011Hemova MedicalBoston, MA, US · est. 2011

Hemova Medical: Innovating robust, safe, and reliable vascular access solutions for hemodialysis.

Angel · $100k2
Avenu MedicalAvenu MedicalSan Juan Capistrano, CA, USHemodialysis Access Systems, Medical Devicesest. 2010Avenu MedicalSan Juan Capistrano, CA, US · est. 2010

Avenu Medical: Innovating vascular access devices for unmet hemodialysis needs.

Series A · $31.4M18
VenoStentVenoStentHouston, TX, USMedical Devicesest. 2017VenoStentHouston, TX, US · est. 2017

VenoStent: Enhancing vascular surgeries with bioabsorbable polymer wraps.

Series A · $22.2M13
Vena MedicalVena MedicalKitchener, Ontario, CAMedical Devices, Microcathetersest. 2016Vena MedicalKitchener, Ontario, CA · est. 2016

Vena Medical offers a microcatheter with the world's smallest camera for in-vessel physician viewing.

Angel · $220k10

Erik van der Burg's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Erik van der Burg

Robert A BermanRobert A BermanBoard Member · enVVeno MedicalFarhad ChowdhuryFarhad ChowdhuryCo-Founder · Vianova HealthS Eric RyanS Eric RyanBoard Member · CornovaAdam MendelsohnAdam MendelsohnCEO · Vivani Medical